AVI BioPharma, Inc. 401k Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 75. This plan is in the top 15% of plans for Salary Deferral. AVI BioPharma, Inc. 401k Plan currently has over 100 active participants and over $4.6M in plan assets.
| Address |
4575 Sw Research Way, Ste 200
Corvallis, OR 97333-1299 |
| Industry | Manufacturing |
| Administrator | J David Boyle II |
| Net Plan Assets | $4,640,000 |
| Total Participants | 100 |
| Avg Account Balance | $45,000 |
| Penwest Pharmaceuticals Co. | 83.2 |
| Supergen | 80.2 |
| Alexza Pharmaceuticals | 80.0 |
| Aveva Drug Delivery Systems | 69.6 |
| XactiMed | 37.8 |
| Actavis Totowa, LLC | 37.2 |
| 1. | Rainier Small/Mid Cap Equity | 16% |
| 2. | T. Rowe Price Growth Stock | 13% |
| 3. | Dodge & Cox International Stock | 12% |
| Insurance Carrier | The Standard |
| Insurance Advisor/Broker | NRP Financial |
| Insurance Advisor/Broker | The National Life Group |
| Insurance Advisor/Broker | Questar Agency, Inc. |
| Insurance Advisor/Broker | Enterprise General Insurance Agency |
| Auditor | KPMG, Llp |
| Recordkeeper | The Standard |

Comments